PHAS / PhaseBio Pharmaceuticals Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5

PhaseBio Pharmaceuticals Inc
US ˙ NASDAQ
HINDI NA ACTIVE ANG SIMBONG ITO

Saham Orang Dalam12,488,536 shares
Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

N/A

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

N/A

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan PhaseBio Pharmaceuticals Inc transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di PHAS / PhaseBio Pharmaceuticals Inc. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2021-08-18 Thorp Clay 10,000 3.0000 10,000 3.0000 30,000 76 4.05 10,500 35.00
2021-08-18 Hutson Nancy J 3,000 3.0800 3,000 3.0800 9,240
2020-12-03 HARRIGAN EDMUND 6,000 4.1200 6,000 4.1200 24,720
2020-11-24 Thorp Clay 2,000 3.5000 2,000 3.5000 7,000
2020-11-23 Thorp Clay 3,000 3.6700 3,000 3.6700 11,010
2018-12-17 Hutson Nancy J 1,000 4.4600 1,000 4.4600 4,460
2018-12-13 Ballance David James 1,000 3.9400 1,000 3.9400 3,940
2018-12-13 Mow Jonathan P 1,000 3.6900 1,000 3.6900 3,690
2018-12-11 York Michael 1,500 3.8800 1,500 3.8800 5,820

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

PHAS / PhaseBio Pharmaceuticals Inc Insider Trades
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di PHAS / PhaseBio Pharmaceuticals Inc. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2022-10-25 NEW ENTERPRISE ASSOCIATES 13 LP 1,784,109 0.1470 1,784,109 0.1470 262,264 8 0.0701 -137,198 -52.31
2021-05-20 Burkhardt Glen 3,811 3.2900 3,811 3.2900 12,538
2020-11-23 Burkhardt Glen 3,497 3.4500 3,497 3.4500 12,065

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

PHAS / PhaseBio Pharmaceuticals Inc Insider Trades
Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas
Tanggal
Perdagangan
Tanggal
Formulir Orang Dalam Ticker Judul Keamanan Kode 10b5-1 Langsung Latihan
Harga
Satuan
Harga
Unit
Diubah
Nilai
Diubah (1 ribu)
Sisa
Pilihan
Sisa
Saham
2023-05-19 2023-05-19 4 Humphries William D. PHAS Common Stock M - Exercise D 2,538 2,538
2023-05-19 2023-05-19 4 Thorp Clay PHAS Common Stock M - Exercise D 3,750 36,693
2023-05-19 2023-05-19 4 van den Broek Richard PHAS Common Stock A - Award D 3,750 0
2023-05-19 2023-05-19 4 Loewy Caroline M PHAS Common Stock M - Exercise D 3,750 3,750
2023-05-19 2023-05-19 4 Sapir Alex PHAS Common Stock M - Exercise D 3,750 3,750
2023-05-19 2023-05-19 4 HARRIGAN EDMUND PHAS Common Stock M - Exercise D 3,750 9,750
2023-05-19 2023-05-19 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3,750 37,510
2022-10-26 2022-10-25 4 NEW ENTERPRISE ASSOCIATES 13 LP PHAS Common Stock S - Sale D 0.1470 -1,784,109 -262 4,857,525
2022-05-24 2022-05-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 0.6813 10,917 7 41,236
2022-05-24 2022-05-20 4 Mow Jonathan P PHAS Common Stock A - Award D 0.6813 10,918 7 132,502
2022-05-24 2022-05-20 4 Hanson Kristopher PHAS Common Stock A - Award D 0.6813 4,831 3 8,463
2022-05-24 2022-05-20 4 Birchall Jonathan PHAS Common Stock A - Award D 0.6813 20,000 14 20,000
2022-05-24 2022-05-23 4 Burkhardt Glen PHAS Common Stock S - Sale D 0.7900 -11,248 -9 0
2022-05-24 2022-05-20 4 Burkhardt Glen PHAS Common Stock A - Award D 0.6813 11,248 8 11,248
2022-05-24 2022-05-20 4 Sharp John P PHAS Common Stock A - Award D 0.6813 6,026 4 65,767
2022-05-20 2021-08-18 4/A Hutson Nancy J Held in an individual retirement account for the benefit of the Reporting Person PHAS Common Stock P - Purchase I 3.0800 3,000 9 4,000
2022-05-20 2022-05-19 4 Thorp Clay PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 Humphries William D. PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 Humphries William D. PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 Loewy Caroline M PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 Sapir Alex PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 Hutson Nancy J PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 van den Broek Richard PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 HARRIGAN EDMUND PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-02-28 2022-02-24 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 1.13 87,500 87,500
2022-02-28 2022-02-24 4 Burkhardt Glen PHAS Restricted Stock Unit A - Award D 18,750 18,750
2022-02-28 2022-02-24 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 1.13 115,500 115,500
2022-02-28 2022-02-24 4 Sharp John P PHAS Restricted Stock Unit A - Award D 24,750 24,750
2022-02-28 2022-02-24 4 Birchall Jonathan PHAS Employee Stock Option (right to buy) A - Award D 1.13 52,500 52,500
2022-02-28 2022-02-24 4 Birchall Jonathan PHAS Restricted Stock Unit A - Award D 11,250 11,250
2022-02-28 2022-02-24 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 1.13 87,500 87,500
2022-02-28 2022-02-24 4 Arnold Susan Elizabeth PHAS Restricted Stock Unit A - Award D 18,750 18,750
2022-02-28 2022-02-24 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 1.13 115,500 115,500
2022-02-28 2022-02-24 4 Lee John Sang PHAS Restricted Stock Unit A - Award D 24,750 24,750
2022-02-28 2022-02-24 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 1.13 385,000 385,000
2022-02-28 2022-02-24 4 Mow Jonathan P PHAS Restricted Stock Unit A - Award D 82,500 82,500
2022-02-28 2022-02-24 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 1.13 87,500 87,500
2022-02-28 2022-02-24 4 Hanson Kristopher PHAS Restricted Stock Unit A - Award D 18,750 18,750
2021-11-23 2021-11-19 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 2.0100 2,559 5 30,319
2021-11-23 2021-11-19 4 Mow Jonathan P PHAS Common Stock A - Award D 2.0100 5,623 11 172,473
2021-11-23 2021-11-19 4 Sharp John P PHAS Common Stock A - Award D 2.0100 2,017 4 59,741
2021-11-23 2021-11-19 4 Hanson Kristopher PHAS Common Stock A - Award D 2.0100 1,545 3 3,632
2021-11-23 2021-11-19 4 Burkhardt Glen PHAS Common Stock S - Sale D 2.3700 -5,766 -14 0
2021-11-23 2021-11-19 4 Burkhardt Glen PHAS Common Stock A - Award D 2.0100 5,766 12 5,766
2021-11-09 2021-11-08 4 Birchall Jonathan PHAS Employee Stock Option (right to buy) A - Award D 3.37 3.3700 250,000 842 250,000
2021-11-08 2021-11-08 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 3.15 3.1500 -7,400 -23 0
2021-11-08 2021-11-08 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3.1500 7,400 23 33,760
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 3.15 3.1500 -1,500 -5 7,400
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 2.26 2.2600 -24,860 -56 2,256
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3.1500 1,500 5 26,360
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Common Stock M - Exercise D 2.2600 24,860 56 24,860
2021-11-03 2021-11-03 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.68 1.6800 -7,500 -13 90,582
2021-11-03 2021-11-03 4 Sharp John P PHAS Common Stock M - Exercise D 1.6800 7,500 13 57,724
2021-11-03 2021-11-03 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1.24 1.2400 -20,000 -25 108,767
2021-11-03 2021-11-03 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1.2400 20,000 25 166,850
2021-09-15 2021-09-14 4 Humphries William D. PHAS Non-employee Director Stock Option (right to buy) A - Award D 2.80 28,000 28,000
2021-09-03 2021-07-12 4/A Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1.74 -4,519 0
2021-09-03 2021-07-12 4/A Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1.7400 4,519 8 27,760
2021-09-03 2021-08-03 4/A Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.68 -7,500 98,082
2021-09-03 2021-08-03 4/A Sharp John P PHAS Common Stock M - Exercise D 1.6800 7,500 13 50,224
2021-08-30 2021-08-27 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1.24 -20,000 128,767
2021-08-30 2021-08-27 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1.2400 20,000 25 146,850
2021-08-19 2021-08-18 4 Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person PHAS Common Stock P - Purchase I 3.0800 3,000 9 4,000
2021-08-18 2021-08-18 4 Thorp Clay PHAS Common Stock P - Purchase D 3.0000 10,000 30 32,943
2021-08-04 2021-08-03 4 Sharp John P PHAS Common Stock A - Award D 1.6800 7,500 13 50,224
2021-07-14 2021-07-12 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 1.7400 4,519 8 27,760
2021-06-04 2021-06-03 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-05-24 2021-05-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 2.8000 5,257 15 23,241
2021-05-24 2021-05-20 4 York Michael PHAS Common Stock A - Award D 2.8000 2,897 8 7,059
2021-05-24 2021-05-20 4 Hanson Kristopher PHAS Common Stock A - Award D 2.8000 1,088 3 2,087
2021-05-24 2021-05-20 4 Mow Jonathan P PHAS Common Stock A - Award D 2.8000 3,964 11 126,850
2021-05-24 2021-05-20 4 Burkhardt Glen PHAS Common Stock S - Sale D 3.2900 -3,811 -13 0
2021-05-24 2021-05-20 4 Burkhardt Glen PHAS Common Stock A - Award D 2.8000 3,811 11 3,811
2021-05-24 2021-05-20 4 Sharp John P PHAS Common Stock A - Award D 2.8000 1,419 4 42,724
2021-02-09 2021-02-05 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 4.31 234,000 234,000
2021-02-09 2021-02-05 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 4.31 36,000 36,000
2021-02-09 2021-02-05 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 4.31 36,000 36,000
2021-02-09 2021-02-05 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 4.31 36,000 36,000
2021-02-09 2021-02-05 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 4.31 76,500 76,500
2021-02-09 2021-02-05 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 4.31 76,500 76,500
2021-02-09 2021-02-05 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 4.31 36,000 36,000
2020-12-04 2020-12-03 4 HARRIGAN EDMUND PHAS Common Stock P - Purchase D 4.1200 6,000 25 6,000
2020-11-24 2020-11-24 4 Thorp Clay PHAS Common Stock P - Purchase D 3.5000 2,000 7 22,943
2020-11-24 2020-11-23 4 Thorp Clay PHAS Common Stock P - Purchase D 3.6700 3,000 11 20,943
2020-11-23 2020-11-20 4 Sharp John P PHAS Common Stock A - Award D 3.0000 1,305 4 41,305
2020-11-23 2020-11-20 4 Hanson Kristopher PHAS Common Stock A - Award D 3.0000 999 3 999
2020-11-23 2020-11-20 4 York Michael PHAS Common Stock A - Award D 3.0000 2,662 8 4,162
2020-11-23 2020-11-20 4 Ballance David James PHAS Common Stock A - Award D 3.0000 919 3 8,519
2020-11-23 2020-11-20 4 Mow Jonathan P PHAS Common Stock A - Award D 3.0000 3,643 11 122,886
2020-11-23 2020-11-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 3.0000 4,832 14 17,984
2020-11-23 2020-11-23 4 Burkhardt Glen PHAS Common Stock S - Sale D 3.4500 -3,497 -12 0
2020-11-23 2020-11-20 4 Burkhardt Glen PHAS Common Stock A - Award D 3.0000 3,497 10 3,497
2020-11-18 2020-11-16 4 Thorp Clay By Catalysta Ventures, LLC PHAS Common Stock J - Other I 10,586 15,432
2020-11-18 2020-11-16 4 Thorp Clay PHAS Common Stock J - Other D 2,144 17,943
2020-11-18 2020-11-16 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock J - Other I -52,397 0
2020-10-05 2020-10-01 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1.15 1.1500 -5,423 -6 0
2020-10-05 2020-10-01 4 Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1.1500 5,423 6 13,152
2020-10-05 2020-02-27 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1.15 1.1500 -5,423 -6 0
2020-10-05 2020-02-27 4 Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1.1500 5,423 6 7,729
2020-08-24 2020-08-21 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1.24 -10,000 148,767
2020-08-24 2020-08-21 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1.2400 10,000 12 119,243
2020-08-17 2020-08-14 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.69 -5,000 105,582
2020-08-17 2020-08-14 4 Sharp John P PHAS Common Stock M - Exercise D 1.6900 5,000 8 40,000
2020-06-05 2020-06-03 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 4,909 4,909
2020-06-05 2020-06-03 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.00 16,000 16,000
2020-06-05 2020-06-03 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 16,000 16,000
2020-06-05 2020-06-03 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 16,000 16,000
2020-06-05 2020-06-03 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 16,000 16,000
2020-06-05 2020-06-03 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 16,000 16,000
2020-06-05 2020-06-03 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 16,000 16,000
2020-02-14 2020-02-12 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 5.19 20,000 20,000
2020-02-14 2020-02-12 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 5.19 55,000 55,000
2020-02-14 2020-02-12 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 5.19 55,000 55,000
2020-02-14 2020-02-12 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 5.19 100,000 100,000
2020-02-14 2020-02-12 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 5.19 55,000 55,000
2020-02-14 2020-02-12 4 Sapir Alex PHAS Employee Stock Option (right to buy) A - Award D 5.19 32,000 32,000
2020-02-14 2020-02-12 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 5.19 100,000 100,000
2020-02-14 2020-02-12 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 5.19 55,000 55,000
2020-02-14 2020-02-12 4 Ballance David James PHAS Employee Stock Option (right to buy) A - Award D 5.19 55,000 55,000
2020-02-14 2020-02-12 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 5.19 290,000 290,000
2019-10-07 2019-10-07 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 4.17 66,000 66,000
2019-09-10 2019-09-06 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1.24 -19,000 158,767
2019-09-10 2019-09-06 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1.2400 19,000 24 109,243
2019-08-22 2019-08-21 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.44 -5,000 4,038
2019-08-22 2019-08-21 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.69 -10,000 110,582
2019-08-22 2019-08-21 4 Sharp John P PHAS Common Stock M - Exercise D 1.4400 5,000 7 35,000
2019-08-22 2019-08-21 4 Sharp John P PHAS Common Stock M - Exercise D 1.6900 10,000 17 30,000
2019-07-03 2019-07-01 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock S - Sale I 14.0000 -459 -6 415,959
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock S - Sale I 14.0000 -255 -4 52,397
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock S - Sale I 14.0000 -180 -3 162,890
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock S - Sale I 14.0000 -2,014 -28 1,818,638
2019-06-20 2019-06-18 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock S - Sale I 14.0000 -63 -1 416,418
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock S - Sale I 14.0000 -35 -0 52,655
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock S - Sale I 14.0000 -25 -0 163,074
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock S - Sale I 14.0000 -277 -4 1,820,656
2019-05-24 2019-05-22 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.69 -15,000 120,582
2019-05-24 2019-05-22 4 Sharp John P PHAS Common Stock M - Exercise D 1.6900 15,000 25 20,000
2019-05-21 2019-05-20 4 Mow Jonathan P PHAS Employee stock option (right to buy) M - Exercise D 1.24 -19,131 0
2019-05-21 2019-05-20 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1.2400 19,131 24 90,243
2019-05-21 2019-05-17 4 Mow Jonathan P PHAS Employee stock option (right to buy) M - Exercise D 2.27 -19,913 0
2019-05-21 2019-05-17 4 Mow Jonathan P PHAS Common Stock M - Exercise D 2.2700 19,913 45 71,112
2019-05-13 2019-05-09 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 11,000 11,000
2019-05-13 2019-05-09 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 11,000 11,000
2019-05-13 2019-05-09 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 9,167 9,167
2019-05-13 2019-05-09 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 4,583 4,583
2019-05-13 2019-05-09 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 2,750 2,750
2019-05-13 2019-05-09 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 11,000 11,000
2019-05-13 2019-05-09 4 Mukhopadhyay Bibhash PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 11,000 11,000
2019-03-01 2019-02-27 4 TUFTS LINDA PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 36,000 36,000
2019-03-01 2019-02-27 4 Ballance David James PHAS Employee Stock Option (right to buy) A - Award D 3.15 45,000 45,000
2019-03-01 2019-02-27 4 Hutson Nancy J PHAS Employee Stock Option (right to buy) A - Award D 3.15 8,900 8,900
2019-03-01 2019-02-27 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 36,000 36,000
2019-03-01 2019-02-27 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 3.15 100,000 100,000
2019-03-01 2019-02-27 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 8,900 8,900
2019-03-01 2019-02-27 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 3.15 100,000 100,000
2019-03-01 2019-02-27 4 Thorp Clay PHAS Employee Stock Option (right to buy) A - Award D 3.15 36,000 36,000
2019-03-01 2019-02-27 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 23,000 23,000
2019-03-01 2019-02-27 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 22,000 22,000
2019-03-01 2019-02-27 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 3.15 45,000 45,000
2019-03-01 2019-02-27 4 Mukhopadhyay Bibhash PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 36,000 36,000
2019-03-01 2019-02-27 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 3.15 263,000 263,000
2019-03-01 2019-02-27 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 3.15 45,000 45,000
2018-12-17 3/A Ballance David James PHAS Common Stock D 6,600
2018-12-17 2018-12-17 4 Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person PHAS Common Stock P - Purchase I 4.4600 1,000 4 1,000
2018-12-17 2018-12-13 4 Ballance David James PHAS Common Stock P - Purchase D 3.9400 1,000 4 7,600
2018-12-17 2018-12-13 4 HARRIGAN EDMUND PHAS Employee Stock Option (right to buy) A - Award D 3.65 68,966 68,966
2018-12-17 2018-12-13 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3.6900 1,000 4 51,199
2018-12-13 2018-12-10 4/A Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3.8500 800 3 50,199
2018-12-13 2018-12-07 4/A Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3.8900 700 3 49,399
2018-12-11 2018-12-10 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3.8500 800 3 51,699
2018-12-11 2018-12-07 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3.8800 2,200 9 50,899
2018-12-11 2018-12-07 4 Sharp John P PHAS Common Stock P - Purchase D 3.8400 5,000 19 5,000
2018-12-11 2018-12-11 4 York Michael PHAS Common Stock P - Purchase D 3.8800 1,500 6 1,500
2018-12-06 2018-12-04 4 Thorp Clay PHAS Common Stock P - Purchase D 3.1300 4,000 13 15,799
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series D Preferred Stock C - Conversion I -1,124,301 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock C - Conversion I -437,706 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -4,349 -22 437,706
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock X - Other I 0.1200 181,190 22 442,055
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0.12 -181,190 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock C - Conversion I -3,279,627 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock S - Sale I 5.0000 -1,177 -6 3,279,627
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock X - Other I 0.1200 49,030 6 3,280,804
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0.12 -49,030 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Common Stock P - Purchase I 5.0000 1,800,000 9,000 6,641,634
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Common Stock C - Conversion I 4,841,634 4,841,634
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock C - Conversion D -2,303 0
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock S - Sale D 5.0000 -3 -0 2,303
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock X - Other D 0.1200 103 0 2,306
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Warrants to Purchase Series B Preferred Stock X - Other D 0.12 -103 0
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Common Stock C - Conversion D 2,303 2,303
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Series B Preferred Stock C - Conversion D -2,306 0
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Series B Preferred Stock M - Exercise D 0.1200 103 0 2,306
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Warrants to Purchase Series B Preferred Stock M - Exercise D 0.12 -103 0
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Common Stock C - Conversion D 2,306 2,306
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series D Preferred Stock C - Conversion I -740,337 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock C - Conversion I -1,664,217 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -2,734 -14 1,664,217
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock X - Other I 0.1200 113,891 14 1,666,951
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0.12 -113,891 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Common Stock P - Purchase I 5.0000 600,000 3,000 3,004,554
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Common Stock C - Conversion I 2,404,554 2,404,554
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series D Preferred Stock C - Conversion I -226,061 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series D Preferred Stock C - Conversion I -24,709 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series D Preferred Stock C - Conversion I -272,107 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock C - Conversion I -40,420 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock C - Conversion I -13,558 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock C - Conversion I -149,320 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock C - Conversion I -94,874 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock C - Conversion I -1,044,764 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series AA Preferred Stock C - Conversion I -13,609 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series AA Preferred Stock C - Conversion I -174,699 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC PHAS Series 1 Preferred Stock C - Conversion I -4,846 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series 1 Preferred Stock C - Conversion I -3,862 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series 1 Preferred Stock C - Conversion I -42,530 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP PHAS Series 1 Preferred Stock C - Conversion I -52,690 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -994 -5 40,420
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock X - Other I 0.1200 41,414 5 41,414
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0.12 -41,414 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -104 -1 13,558
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock X - Other I 0.1200 4,309 1 13,662
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0.12 -4,309 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -1,139 -6 149,320
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock X - Other I 0.1200 47,458 6 150,459
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0.12 -47,458 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -42 -0 94,874
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock X - Other I 0.1200 1,731 0 94,916
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0.12 -1,731 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -458 -2 1,044,764
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock X - Other I 0.1200 19,061 2 1,045,222
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0.12 -19,061 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Common Stock P - Purchase I 5.0000 150,000 750 416,481
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Common Stock C - Conversion I 266,481 266,481
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC PHAS Common Stock C - Conversion I 4,846 4,846
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Common Stock P - Purchase I 5.0000 12,487 62 163,099
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Common Stock C - Conversion I 150,612 150,612
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Common Stock P - Purchase I 5.0000 137,513 688 1,820,933
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Common Stock C - Conversion I 1,683,420 1,683,420
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP PHAS Common Stock C - Conversion I 52,690 52,690
2018-10-24 2018-10-22 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Series B Preferred Stock C - Conversion I -3,505 0
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Series B Preferred Stock C - Conversion D -310 0
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Series B Preferred Stock M - Exercise D 0.1200 310 0 310
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Warrants to Purchase Series B Preferred Stock M - Exercise D 0.12 -310 0
2018-10-24 2018-10-22 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock C - Conversion I 3,505 48,699
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Common Stock C - Conversion D 310 310
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series D Preferred Stock C - Conversion I -226,061 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series D Preferred Stock C - Conversion I -24,709 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series D Preferred Stock C - Conversion I -272,107 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock C - Conversion I -40,420 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock C - Conversion I -13,558 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock C - Conversion I -149,320 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock C - Conversion I -94,874 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock C - Conversion I -1,044,764 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series AA Preferred Stock C - Conversion I -13,609 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series AA Preferred Stock C - Conversion I -174,699 0
2018-10-24 2018-10-22 4 Thorp Clay By Catalysta Ventures, LLC PHAS Series 1 Preferred Stock C - Conversion I -4,846 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series 1 Preferred Stock C - Conversion I -3,862 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series 1 Preferred Stock C - Conversion I -42,530 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Series 1 Preferred Stock C - Conversion I -52,690 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -994 -5 40,420
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 41,414 5 41,414
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -41,414 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -104 -1 13,558
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 4,309 1 13,662
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -4,309 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -1,139 -6 149,320
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 47,458 6 150,459
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -47,458 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -42 -0 94,874
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock M - Exercise I 0.1200 1,731 0 94,916
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0.12 -1,731 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -458 -2 1,044,764
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock M - Exercise I 0.1200 19,061 2 1,045,222
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0.12 -19,061 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock P - Purchase I 5.0000 150,000 750 416,481
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock C - Conversion I 266,481 266,481
2018-10-24 2018-10-22 4 Thorp Clay By Catalysta Ventures, LLC PHAS Common Stock C - Conversion I 4,846 4,846
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock P - Purchase I 5.0000 12,487 62 163,099
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock C - Conversion I 150,612 150,612
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock P - Purchase I 5.0000 137,513 688 1,820,933
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock C - Conversion I 1,683,420 1,683,420
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock C - Conversion I 52,690 52,690
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series D Preferred Stock C - Conversion I -30,334 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series D Preferred Stock C - Conversion I -6,413 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series D Preferred Stock C - Conversion I -63,688 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock C - Conversion I -22,452 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock C - Conversion I -4,746 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock C - Conversion I -47,140 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock C - Conversion I -165,395 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock C - Conversion I -34,968 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock C - Conversion I -347,250 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series AA Preferred Stock C - Conversion I -56,874 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series AA Preferred Stock C - Conversion I -12,025 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series AA Preferred Stock C - Conversion I -119,408 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -113 -1 22,452
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 4,690 1 22,565
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -4,690 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -24 -0 4,746
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 991 0 4,770
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -991 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -237 -1 47,140
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 9,847 1 47,377
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -9,847 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -81 -0 165,395
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock M - Exercise I 0.1200 3,359 0 165,476
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0.12 -3,359 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -18 -0 34,968
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock M - Exercise I 0.1200 710 0 34,986
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0.12 -710 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -170 -1 347,250
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock M - Exercise I 0.1200 7,053 1 347,420
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0.12 -7,053 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Common Stock P - Purchase I 5.0000 6,041 30 281,096
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Common Stock C - Conversion I 275,055 275,055
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Common Stock P - Purchase I 5.0000 1,277 6 59,429
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Common Stock C - Conversion I 58,152 58,152
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Common Stock P - Purchase I 5.0000 12,682 63 590,168
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Common Stock C - Conversion I 577,486 577,486
2018-10-17 2018-10-17 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 5.00 220,000 220,000
2018-10-17 3 Thorp Clay PHAS Common Stock D 23,598
2018-10-17 3 Thorp Clay PHAS Common Stock D 23,598
2018-10-17 3 Thorp Clay PHAS Common Stock D 23,598
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90,388
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90,388
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90,388
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista